Skip to content

Clinical trials

Autoimmune Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: South Korea Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20122
20132
20141
20151
20181
20191
20204
20211
20222
20233
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting9
Active, not recruiting4
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
GlaxoSmithKline2
Human Genome Sciences Inc., a GSK Company2
Pfizer2
Seoul National University Hospital2
Takeda2
Viatris Innovation GmbH2
Alumis Inc1
Anthera Pharmaceuticals1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases32
Immune System Diseases12
Lupus Erythematosus, Systemic11
Connective Tissue Diseases7
Arthritis, Rheumatoid5
Glomerulonephritis4
Kidney Diseases4
Nephritis4
Glomerulonephritis, IGA3
Sjogren's Syndrome3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.